Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial

医学 林奇综合征 内科学 肿瘤科 结直肠癌 随机对照试验 临床试验 外科 梅德林 妇科
作者
Robert Hüneburg,Querijn N.E. van Bokhorst,María Pellisé,Francesc Balaguer,Angelo Brunori,Thomas Rösch,Deepak Vangala,Kien Vu Trung,Arne Kandulski,Britt B. S. L. Houwen,Hanneke Beaumont,Dewkoemar Ramsoekh,Christian P. Strassburg,Raf Bisschops,Alexander Link,Tim Marwitz,J Rogee,Katrin van Beekum,Christoph Engel,Evelien Dekker
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier BV]
卷期号:11 (10): 875-886 被引量:5
标识
DOI:10.1016/s2468-1253(26)00163-9
摘要

BACKGROUND: Artificial intelligence (AI)-based computer-aided detection (CADe) systems improve adenoma detection in average-risk colorectal cancer screening. Meanwhile, evidence in Lynch syndrome surveillance is sparse and inconsistent. We assessed the effect of CADe on adenoma detection during Lynch syndrome surveillance. Computer-aided optical diagnosis (CADx) performance for optical differentiation of colorectal lesions was evaluated as a secondary aim. METHODS: CADLY2 was an international, multicentre, open-label, randomised controlled superiority trial at nine specialised hereditary cancer surveillance centres in Belgium, Germany, the Netherlands, and Spain. Adults aged 18 years or older with genetically confirmed Lynch syndrome scheduled for surveillance colonoscopy were randomly assigned (1:1) to high-definition white-light (HD-WL) colonoscopy alone or to HD-WL colonoscopy with computer-aided assistance from CAD EYE (Fujifilm, Tokyo, Japan). CAD EYE was used for CADe during withdrawal and for CADx after lesion detection. Randomisation was done centrally through a secure web-based system using Pocock's minimisation algorithm with a stochastic component and was stratified by centre, sex, previous colorectal cancer, underlying pathogenic variant, and interval since previous colonoscopy. Allocation concealment was ensured through the centralised web-based system. Patients were masked to group allocation until the start of withdrawal in procedures with mild sedation, or until completion of the procedure in procedures with propofol-based sedation. Endoscopists were not masked. The primary outcome was adenoma detection rate, defined as the proportion of patients with at least one histopathologically confirmed adenoma, analysed in the full analysis set (defined as all randomly allocated patients with available data for the primary outcome). The diagnostic performance of the CADx system was evaluated as a secondary outcome. The safety analysis set comprised all randomly allocated patients who underwent a study colonoscopy. This study is registered with the German Clinical Trials Register, DRKS00030695, and is completed. FINDINGS: Between May 9, 2023, and Oct 30, 2025, 757 patients were randomly allocated to HD-WL colonoscopy (377 patients) or to AI-assisted colonoscopy (380 patients); 733 patients were included in the full analysis set (369 HD-WL and 364 AI-assisted). The median age was 49 years (IQR 38-59) in the HD-WL group and 50 years (38-59) in the AI-assisted group; 213 (58%) were female and 156 (42%) male in the HD-WL group, and 207 (57%) were female and 157 (43%) male in the AI-assisted group. The adenoma detection rate was 30·9% (114 of 369 patients) with HD-WL versus 33·8% (123 of 364 patients) with CADe assistance (odds ratio 1·14 [95% CI 0·83-1·57], p=0·41). For CADx differentiation of neoplastic versus non-neoplastic lesions in the paired lesion-level analysis, with histopathology as the reference standard and sessile serrated lesions and traditional serrated adenomas classified as non-neoplastic, CADx sensitivity was 85·9% (95% CI 82·0-89·1) and specificity was 91·4% (89·4-93·0). Three adverse events occurred in the AI-assisted group: two mild post-polypectomy bleedings and one serious pulmonary embolism or deep venous thrombosis unrelated to the procedure. No adverse events occurred in the HD-WL group. INTERPRETATION: CADe-assisted colonoscopy did not show the absolute improvement in adenoma detection rate that was assumed in the prespecified sample-size calculation. CADx did not clearly improve lesion differentiation beyond expert optical diagnosis in expert Lynch syndrome surveillance settings. FUNDING: Third-party research funding of the National Center for Hereditary Tumor Syndromes, University Hospital Bonn.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
情怀的应助被橘子采纳,获得10
刚刚
hxy完成签到 ,获得积分10
1秒前
秋萍完成签到,获得积分10
1秒前
万万完成签到,获得积分10
1秒前
Loongwhm完成签到,获得积分0
1秒前
1秒前
1秒前
传奇3的应助被八戒的梦想采纳,获得10
1秒前
沐沐完成签到,获得积分10
1秒前
1秒前
眼科女医生小魏完成签到 ,获得积分10
1秒前
Hello的应助被要减肥冬天采纳,获得10
1秒前
左丘以云完成签到,获得积分10
2秒前
2秒前
2秒前
拉姆完成签到,获得积分10
2秒前
i1完成签到 ,获得积分10
3秒前
怕孤单的凌瑶完成签到,获得积分20
3秒前
lvh111完成签到,获得积分10
3秒前
LZNUDT发布了新的文献求助10
3秒前
3秒前
背后的大门完成签到,获得积分10
3秒前
科研通AI6.4的应助被啵啵采纳,获得10
3秒前
4秒前
4秒前
Funnymudpee完成签到,获得积分10
4秒前
yonglong完成签到,获得积分10
5秒前
e00ec发布了新的文献求助10
5秒前
科研通AI6.4的应助被youyou采纳,获得10
5秒前
Sakura完成签到,获得积分10
5秒前
孟寐以求完成签到,获得积分10
5秒前
核桃发布了新的文献求助10
5秒前
李永畅完成签到,获得积分10
6秒前
6秒前
丘溪4761完成签到,获得积分10
6秒前
小马甲的应助被LZNUDT采纳,获得10
6秒前
7秒前
丘比特的应助被anan27采纳,获得30
7秒前
魔幻书瑶完成签到,获得积分10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159581
求助须知:如何正确求助?哪些是违规求助? 9555100
关于积分的说明 21724719
捐赠科研通 7749543
什么是DOI,文献DOI怎么找? 3427281
关于科研通互助平台的介绍 2552278
邀请新用户注册赠送积分活动 2471619